Clinical Trial

Association of Gestational Cardiovascular Health With Pregnancy Outcomes

Recruiting
View on ClinicalTrials.gov →
Summary
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-07.
Trial Details
NCT Number NCT05776082
Lead Sponsor Women's Hospital School Of Medicine Zhejiang University
Conditions Pregnant Women
Enrollment 5,000 participants
Start Date 2023-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-29